Chu Shelley
SEC insider (Form 3/4/5 filer). CIK 0001895958. Director at Odyssey Therapeutics, Inc. (ODTX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 11, 2026. Located in BOSTON, MA.
Companies Chu Shelley has filed insider reports for
- Odyssey Therapeutics, Inc. (ODTX): Director
- HilleVax, Inc. (HLVX): Director
Chu Shelley
CIK: 0001895958
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 11, 2026ODTX
Odyssey Therapeutics, Inc.
PurchaseDirect11.1K shares at avg. $18.00$200K - Sep 17, 2025HLVX
HilleVax, Inc.
Tender OfferDirect17.2K shares- - Jun 23, 2025HLVX
HilleVax, Inc.
AwardDirect17.2K shares- - Jun 6, 2024HLVX
HilleVax, Inc.
AwardDirectStock Option
22.5K shares-
1-4 of 4 transactions